Table 3 Quality of life and cognition test scores before and three months after the start of preventive treatment in patients with CM
From: Preventive treatment can reverse cognitive impairment in chronic migraine
Pre-treatment (n = 46) \(\overline{\mathbf x}\;(\mathbf S\mathbf D)\) | Post-treatment (n = 40) \(\overline{\mathbf x}\;(\mathbf S\mathbf D)\) | P Value | |
|---|---|---|---|
Migraine | |||
Frequency | 21.58 (5.96) | 9.54 (9.8) | 0.000 |
Intensity | 8.25 (1.42) | 6.24 (1.98) | 0.000 |
Cognitive measures | |||
ROCF-c / TFT-c | 30.09 (5.4) | 30.98 (4.95) | 0.227 |
ROCF-m / TFT-m | 15.78 (7.01) | 19.6 (7.55) | 0.000 |
TMT-A | 56.79 (48.25) | 44.14 (30.31) | 0.007 |
TMT-B | 112.04 (49.99) | 104.19 (56.88) | 0.080 |
Emotional state | |||
HADS—A | 9.69 (4.04) | 9.38 (4.79) | 0.485 |
HADS—D | 7.91 (4.71) | 7.45 (4.86) | 0.171 |
BDI-II | 18.2 (13.4) | 15.23 (13.52) | 0.052 |
Quality of life | |||
SF-36 PF | 67.93 (22.42) | 69.73 (25.74) | 0.679 |
SF-36 RP | 20.65 (31.76) | 28.75 (36.93) | 0.305 |
SF-36 BP | 26.58 (23.16) | 31.48 (19.07) | 0.040 |
SF-36 GH | 39.24 (19.63) | 45.13 (19.82) | 0.003 |
SF-36 VT | 48.57 (81.38) | 39.85 (18) | 0.830 |
SF-36 SF | 53.53 (26.44) | 58.75 (26.88) | 0.386 |
SF- 36 RE | 42.78 (46.98) | 60 (43.51) | 0.091 |
SF-36 MH | 53.11 (19.61) | 57.33 (21.22) | 0.294 |
PSQI-GS | 10.49 (4.65) | 8.97 (4.82) | 0.025 |